Our Featured Experts

Renier J. Brentjens, MD, PhD
Dr. Brentjens on Managing Patients After CAR T-Cell Therapy
Renier J. Brentjens, MD, PhD, associate professor, chief, Cellular Therapeutics Center, Memorial Sloan Kettering Cancer Center, discusses managing patients after treatment with chimeric antigen receptor (CAR) T-cell therapy.
 
Elizabeth Plimack, MD
Oncology Specialists
Publication Bottom Border
Border Publication
x